IP Library Assignment 024061/0255
Patent Assignment
Reel/Frame 024061/0255

Merger

Recorded: 2010-03-10 Pages: 9
Assignors
APEX MERGER SUB, INC.
Executed: 2009-04-17
CV THERAPEUTICS, INC.
Executed: 2009-04-17
Assignee
GILEAD PALO ALTO, INC.
333 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA, 94404
Covered Property (1)
Use of A2A Adenosine Receptor Agonists in the Treatment of Ischemia
Application: 11/766,964 →
Publication: US 2007/0299089
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Apr 16, 2008
From: CV THERAPEUTICS, INC.
To: TPG-AXON ROYALTY TRUST
Reel/Frame 020808/0823 →
Merger Oct 6, 2009
From: GILEAD PALO ALTO, INC.
To: TPG-AXON ROYALTY TRUST
Reel/Frame 023330/0648 →
Assignment of Assignor's Interest Jan 6, 2010
From: TPG-AXON ROYALTY TRUST
To: TPG-AXON LEX SUB-TRUST
Reel/Frame 023731/0916 →
Assignment of Assignor's Interest Mar 10, 2010
From: BELARDINELLI, LUIZ; DHALLA, ARVINDER
To: GILEAD PALO ALTO, INC.
Reel/Frame 024061/0251 →
Assignment of Assignor's Interest Jun 10, 2011
From: GILEAD PALO ALTO, INC.
To: GILEAD SCIENCES, INC.
Reel/Frame 026424/0925 →